Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 SSO Annual Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Speaker
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
L
La Ferlita, Alessandro
The Ohio State University
P57: Phosphorylation of IWS1 by AKT Maintains Liposarcoma Tumor Heterogeneity through Preservation of Cancer Stem Cell Phenotypes and Mesenchymal-Epithelial Plasticity
Location:SSO HUB: Melanoma & Sarcoma Zone
Alessandro La Ferlita
Labow, Daniel
Icahn School of Medicine at Mount Sinai
P80: Accuracy of Clinical Staging for Intramural (T2) Gastric Cancer: Survival Outcomes Following Upfront Surgical Resection Compared to Risk of Overtreatment with Neoadjuvant Therapy
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Daniel Labow
Lahat, Guy
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
90: Obesity and Gastric Cancer Aggressiveness – a New Link
Location:Veterans Memorial Auditorium
Guy Lahat
P81: Neoadjuvant Chemotherapy for Gastric Cancer in the Elderly: Are We Accomplishing Our Treatment Goals or Should we Consider an Upfront Surgery Approach
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Guy Lahat
Landry, Jace
LSU HSC New Orleans
30: Cytoreduction in Patients with Metastatic Pancreatic Neuroendocrine Tumors and the Clinical Factors Driving Outcomes
Location:Ballroom A
Jace Landry
Laronga, Christine
H. Lee Moffitt Cancer Center & Research Institute
Management of the Clinically Node Positive Axilla with Upfront Surgery
Location:Ballroom B
Christine Laronga
Questions and Discussion
Location:Ballroom B
Christine Laronga
Lauer, Kathryn
Medical College of Wisconsin, Department of Anesthesiology
87: Identifying Optimal Surgical Timing Relative to SARS-CoV-2 Infection Using COVID-19 Severity in Cancer Patients
Location:Ballroom B
Kathryn Lauer
Lauwers, Gregory
Moffitt Cancer Center
97: Long-term Oncologic Outcomes Following Pathologic Complete Response (pCR) for Esophageal Cancer
Location:Ballroom A
Gregory Lauwers
Lazar, Alexander
MD Anderson Cancer Center
95: Cancer Testis Antigen and Interleukin Expression Correlates with Survival in Small Bowel Neuroendocrine Tumors
Location:Ballroom A
Alexander Lazar
Lazcano Segura, Rossana
MD Anderson Cancer Center
95: Cancer Testis Antigen and Interleukin Expression Correlates with Survival in Small Bowel Neuroendocrine Tumors
Location:Ballroom A
Rossana Lazcano Segura
Lebbe, Céleste
Université de Paris and CIC AP-HP Hôpital Saint Louis
60: Safety, efficacy, and biomarker assessment of RP1 in combination with nivolumab in patients with advanced skin cancers
Location:Veterans Memorial Auditorium
Céleste Lebbe
LeCompte, Michael
University of North Carolina School of Medicine
43: Optimal Duration of Chemotherapy in the Era of Neoadjuvant Therapy for Pancreatic Adenocarcinoma - Is There a Magic Number?
Location:Ballroom B
Michael LeCompte
Lee, Byrne
Stanford University School of Medicine
78: Detection of Circulating Tumor DNA Predicts Recurrence in Soft Tissue Sarcomas
Location:Ballroom A
Byrne Lee
Beyond HIPEC: Management of Limited Peritoneal Disease in Gastric Cancer
Location:SSO HUB Theater
Byrne Lee
Tumor Board/Case Presentations
Location:SSO HUB Theater
Byrne Lee
Lee, Hyuk-Joon
Seoul National University Hospital
92: Long-term outcomes of proximal gastrectomy for upper third advanced gastric and Siewert type II esophagogastric junction cancers in comparison with total gastrectomy: a propensity-score matched analysis
Location:Ballroom A
Hyuk-Joon Lee
Lee, Jeffrey
MD Anderson Cancer Center
P39: Effect of Surgical Approach on Early Return to Intended Oncologic Therapy After Resection for Pancreatic Ductal Adenocarcinoma
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Jeffrey Lee
Lee, Lawrence
McGill University Health Centre
ERAS Colorectal Surgery Update: Is Same Day Colectomy Ready for Primetime?
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Lawrence Lee
Lee, Minna
Memorial Sloan Kettering Cancer Center
P11: Satisfaction and well-being after contralateral prophylactic mastectomy among BRCA mutation carriers and non-carriers: a longitudinal analysis of BREAST-Q domains
Location:SSO HUB: Breast & Endocrine Zone
Minna Lee
Lee, Rachel
Emory University
37: Hepatic Artery Infusion Chemotherapy Compared to Y90 for Treatment of Unresectable Colorectal Liver Metastases: A Multi-Institutional Comparative Study
Location:Ballroom B
Rachel Lee
Lei, Xiudong
American Society of Clinical Oncology Center for Research and Analytics
16: Association of Medicaid Expansion with reduction in racial disparities in the timely delivery of up-front surgical care for patients with early stage breast cancer
Location:Veterans Memorial Auditorium
Xiudong Lei
Lelièvre, Loïc
Breast center, CHUV, Lausanne, Switzerland
17: Axillary dissection to determine nodal burden to inform systemic therapy recommendations for clinically node-positive breast cancer: Pre-planned substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Loïc Lelièvre
Leo, Cornelia
Breast Center, Cantonal Hospital Baden, Baden, Switzerland
17: Axillary dissection to determine nodal burden to inform systemic therapy recommendations for clinically node-positive breast cancer: Pre-planned substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Cornelia Leo
Leonard, Laura
University of Colorado School of Medicine, Department of Surgery
P9: Comparing Patient Reported Outcomes for Same-day Discharge and Inpatient Admission After Mastectomy
Location:SSO HUB: Breast & Endocrine Zone
Laura Leonard
LePetross, H. Clarissa
MD Anderson Cancer Center
1: Impact of Breast Conservation Therapy on Local Recurrence in Patients with Multiple Ipsilateral Breast Cancer – Results from ACOSOG Z11102 (Alliance)
Location:Veterans Memorial Auditorium
H. Clarissa LePetross
Lesinski, Gregory
Emory University
55: Neoadjuvant Pepinemab in Combination with Nivolumab and/or Ipilimumab in Resectable Stage III Melanoma
Location:Veterans Memorial Auditorium
Gregory Lesinski
Lessing, Yonatan
Tel Aviv Sourasky Medical Center
P81: Neoadjuvant Chemotherapy for Gastric Cancer in the Elderly: Are We Accomplishing Our Treatment Goals or Should we Consider an Upfront Surgery Approach
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Yonatan Lessing
Le, Tiana
Memorial Sloan Kettering Cancer Center
P11: Satisfaction and well-being after contralateral prophylactic mastectomy among BRCA mutation carriers and non-carriers: a longitudinal analysis of BREAST-Q domains
Location:SSO HUB: Breast & Endocrine Zone
Tiana Le
P73: How much does postoperative pain interfere with activities of daily living after breast surgery?
Location:SSO HUB: Rare/Metastatic Cancers Zone
Tiana Le
Levine, Edward
Wake Forest University
65: Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH Sensitive Imaging Agent: Topline Results from a Phase 2 Study
Location:Veterans Memorial Auditorium
Edward Levine
66: Utilizing Organoids to Study Perfusate Selection in Appendiceal Cancer Patients Undergoing Repeat HIPEC
Location:Ballroom B
Edward Levine
68: Assessing the Mucolytic and Cytotoxic Activity of Bromelain in Appendiceal Cancer Organoids
Location:Ballroom B
Edward Levine
CRS and HIPEC for Unusual Primaries
Location:SSO HUB Theater
Edward Levine
Lewin, David
Medical University of South Carolina
45: Differential Immune Signatures are Associated with Racial Disparities in Pancreatic Cancer
Location:Ballroom A
David Lewin
Lewis, Aaron
City of Hope
P35: Slow Adoption of Observation for Small Pancreatic Neuroendocrine Tumors
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Aaron Lewis
Lew, Michael
City of Hope National Medical Center
P54: A comparative evaluation of efficacy endpoints in colorectal and appendiceal carcinomatosis treated with PIPAC: Secondary analysis of a US multicenter phase 1 trial
Location:SSO HUB: Rare/Metastatic Cancers Zone
Michael Lew
Li, Amy
Stanford University School of Medicine
37: Hepatic Artery Infusion Chemotherapy Compared to Y90 for Treatment of Unresectable Colorectal Liver Metastases: A Multi-Institutional Comparative Study
Location:Ballroom B
Amy Li
78: Detection of Circulating Tumor DNA Predicts Recurrence in Soft Tissue Sarcomas
Location:Ballroom A
Amy Li
Li, Daneng
City of Hope
P35: Slow Adoption of Observation for Small Pancreatic Neuroendocrine Tumors
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Daneng Li
Lidsky, Michael
Duke University
52: Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.
Location:Ballroom A
Michael Lidsky
P29: Hepatic resection for metastatic pancreatic ductal adenocarcinoma – a prospective single institution pilot study
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Michael Lidsky
P33: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Michael Lidsky
P60: Evolution in management of upfront treatment for desmoid tumors
Location:SSO HUB: Melanoma & Sarcoma Zone
Michael Lidsky
P79: Impact of Tumor Size and Management on Survival in Gastric GIST
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Michael Lidsky
Li, Isabel
Melanoma Institute Australia; The University of Sydney
P44: A Tool For Predicting The Risk Of Death From Melanoma And Competing Causes At Varying Time Intervals After Diagnosis
Location:SSO HUB: Melanoma & Sarcoma Zone
Isabel Li
Lillemoe, Heather
The University of Texas MD Anderson Cancer Center
P74: Perceptions of Readiness for Practice after Complex General Surgical Oncology Fellowship: A Survey Study
Location:SSO HUB: Rare/Metastatic Cancers Zone
Heather Lillemoe
Lim, David
Women's College Research Institute, Women's College Hospital & University of Toronto Department of Surgery
6: Population-based survival outcomes of pure vs mixed invasive Lobular Breast Carcinoma in Ontario, Canada
Location:Veterans Memorial Auditorium
David Lim
Lim, Dean
City of Hope National Medical Center
P54: A comparative evaluation of efficacy endpoints in colorectal and appendiceal carcinomatosis treated with PIPAC: Secondary analysis of a US multicenter phase 1 trial
Location:SSO HUB: Rare/Metastatic Cancers Zone
Dean Lim
Li, Meng
MD Anderson Cancer Center
16: Association of Medicaid Expansion with reduction in racial disparities in the timely delivery of up-front surgical care for patients with early stage breast cancer
Location:Veterans Memorial Auditorium
Meng Li
Lindsay, Hunter
BYU
39: Mechanoresponsive Pancreatic Ductal Adenocarcinoma Cancer Associated Fibroblasts Shows an FAK-Dependent Subtype Divergent from Canonical Fibrotic TGFB-Pathway Dependence
Location:Ballroom B
Hunter Lindsay
Linehan, David
University of Rochester Medical Center
38: Semaphorin 4D is Expressed by Activated Lymphocytes in Pancreatic Adenocarcinoma, and Monoclonal Blockade Sensitizes Murine Tumors to Immune Checkpoint Therapy
Location:Ballroom B
David Linehan
44: Pten deletion-induced murine model of cholangiocarcinoma: a pathologic and immune analysis
Location:Ballroom B
David Linehan
46: Pan-Lysyl Oxidase Inhibition Disrupts Macrophage Invasion and Renders Tumor-Associated Macrophages Susceptible to Cytotoxic Chemotherapy in Cholangiocarcinoma
Location:Ballroom A
David Linehan
P34: Determining Safety and Tolerability of SX-682 in Combination with Anti-PD1 as Maintenance Therapy for Unresectable Pancreatic Adenocarcinoma, A Phase I Study
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
David Linehan
Lin, Heather
MD Anderson Cancer Center
5: Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection
Location:Veterans Memorial Auditorium
Heather Lin
Lin, Sabrina
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center
21: Organ Preservation, Compliance and Toxicity in Rectal Cancer Patients Treated with Total Neoadjuvant Therapy: A Post Hoc Analysis of the of the OPRA Phase II Trial
Location:Ballroom C
Sabrina Lin
Lipton, Zachary
Carnegie Mellon University
P56: A Data Driven Approach for Individualized Risk Prediction of Serious Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Location:SSO HUB: Rare/Metastatic Cancers Zone
Zachary Lipton
Liu, Anni
New York-Presbyterian Weill Cornell Medicine
P8: Breast Cancer Among Asian Women in New York City: Disparities in Presentation and the Need for Disaggregated Data
Location:SSO HUB: Breast & Endocrine Zone
Anni Liu
Liu, Annie
Duke University Medical Center
52: Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.
Location:Ballroom A
Annie Liu
Liu, Minetta
Natera
P33: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Minetta Liu
Liu, Yanan
University of Iowa Hospitals and Clinics - 200 Hawkins DriveC52-P General HospitalIowa City, IA 52242UNITED STATES - Iowa City, IA
42: Machine-learning based investigation of prognostic indicators for oncological outcome of pancreatic ductal adenocarcinoma
Location:Ballroom B
Yanan Liu
Li, Yingjoy
UCI Medical School
P49: Convolutional Neural Network to Predict Peritoneal Carcinomatosis Risk in Gastric Cancer
Location:SSO HUB: Rare/Metastatic Cancers Zone
Yingjoy Li
Li, Zibo
University of North Carolina
29: Development of a novel PET agent for parathyroid imaging targeting the Calcium-Sensing Receptor (CaSR)
Location:Ballroom A
Zibo Li
Loewenstein, Shelly
Tel-Aviv Sourasky Medical Center and Tel-Aviv University
90: Obesity and Gastric Cancer Aggressiveness – a New Link
Location:Veterans Memorial Auditorium
Shelly Loewenstein
Longaker, Michael
Stanford University
39: Mechanoresponsive Pancreatic Ductal Adenocarcinoma Cancer Associated Fibroblasts Shows an FAK-Dependent Subtype Divergent from Canonical Fibrotic TGFB-Pathway Dependence
Location:Ballroom B
Michael Longaker
Long, Georgina
Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia
54: Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Tumor Location in the Phase 3 KEYNOTE-716 Study
Location:Veterans Memorial Auditorium
Georgina Long
63: Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)
Location:Veterans Memorial Auditorium
Georgina Long
Long, Mark
Roswell Park Comprehensive Cancer Center - Department of Biostatistics and Bioinformatics
94: Single-cell profiling of tumor-infiltrating T-cell clones in longitudinal peripheral blood samples for clinical studies
Location:Ballroom A
Mark Long
Lopez-Aguiar, Alexandra
The Ohio State University Wexner Medical Center
P76: Surgeon Perspectives on Management of Aborted Cancer Surgery: Results of an SSO Member Survey
Location:SSO HUB: Rare/Metastatic Cancers Zone
Alexandra Lopez-Aguiar
Lopez-Ramirez, Felipe
Mercy Medical Center
24: Sufficient Regional Lymph Node Examination for Staging High-Grade Appendix Cancer
Location:Ballroom C
Felipe Lopez-Ramirez
Lorello, Gianni
University of Toronto
84: The association between familiarity of the surgeon-anesthesiologist dyad and post-operative patient outcomes for complex gastrointestinal cancer surgery: a population-based study.
Location:Ballroom B
Gianni Lorello
Loria, Anthony
University of Rochester Medical Center
85: Impact of Incident Hospital-Acquired Geriatric Syndromes on Short-term Outcomes following Gastrointestinal Cancer Resection
Location:Ballroom B
Anthony Loria
Lo, Serigne
Melanoma Institute Australia; The University of Sydney
56: International Validation Study of the Melanoma Institute Australia Sentinel Node Metastasis Risk Nomogram
Location:Veterans Memorial Auditorium
Serigne Lo
59: Validating the Use of Surrogate Endpoints to Assess the Survival Outcomes of Melanoma Patients in Clinical Trials
Location:Veterans Memorial Auditorium
Serigne Lo
P44: A Tool For Predicting The Risk Of Death From Melanoma And Competing Causes At Varying Time Intervals After Diagnosis
Location:SSO HUB: Melanoma & Sarcoma Zone
Serigne Lo
Louie, Anna
Duke University
P7: Genomic characterization of breast cancer metastases reveals differences in rates of PIK3CA mutation across metastatic sites and worse survival in patients with concurrent CDH1 mutation treated with PI3K inhibitor
Location:SSO HUB: Breast & Endocrine Zone
Anna Louie
Louie, Raphael
Virginia Commonwealth University, Department of Surgery
13: Luminal A vs B After Choosing Wisely: Do Phenotypes Affect Oncologic Outcomes?
Location:Veterans Memorial Auditorium
Raphael Louie
Lourdault, Kristel
Saint John's cancer institute
P47: Predicting recurrence after a negative sentinel lymph node in melanoma: the model changes with time and sites of recurrence
Location:SSO HUB: Melanoma & Sarcoma Zone
Kristel Lourdault
Love, Madeleine
CITY OF HOPE CANCER CENTER
P78: Pilot Study of a Telehealth Intervention for Self-Management of Eating after Gastroesophageal Cancer Surgery
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Madeleine Love
Lowe, Michael
Emory University School of Medicine
53: Surgical Outcomes of SWOG1801: Neoadjuvant/adjuvant versus adjuvant pembrolizumab for resectable stage III-IV melanoma
Location:Veterans Memorial Auditorium
Michael Lowe
55: Neoadjuvant Pepinemab in Combination with Nivolumab and/or Ipilimumab in Resectable Stage III Melanoma
Location:Veterans Memorial Auditorium
Michael Lowe
P41: A Multi-Institution Observational Analysis of the Theory of the Immunization Effect in Patients with Multiple Primary Melanomas
Location:SSO HUB: Melanoma & Sarcoma Zone
Michael Lowe
Lowy, Andrew
UC San Diego
Sharks
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Andrew Lowy
Lubezky, Nir
Tel-Aviv Sourasky Medical Center
90: Obesity and Gastric Cancer Aggressiveness – a New Link
Location:Veterans Memorial Auditorium
Nir Lubezky
Lucci, Anthony
The University of Texas MD Anderson Cancer Center
5: Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection
Location:Veterans Memorial Auditorium
Anthony Lucci
7: Multicenter clinical trial for omission of breast surgery in invasive cancer following neoadjuvant systemic therapy: Longitudinal patient reported outcomes and decisional comfort planned analyses
Location:Veterans Memorial Auditorium
Anthony Lucci
PRO: Stage IV Breast Cancer Patients Benefit from Surgery
Location:Veterans Memorial Auditorium
Anthony Lucci
Rebuttal and Q & A
Location:Veterans Memorial Auditorium
Anthony Lucci
Luke, Jason
Cancer Immunotherapeutics Center, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA
54: Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Tumor Location in the Phase 3 KEYNOTE-716 Study
Location:Veterans Memorial Auditorium
Jason Luke
Lu, Pamela
MD Anderson Cancer Center
100: Robotic Subtotal Gastrectomy with D2 Lymph Node Dissection using Indocyanine Green Sentinel Lymphatic Mapping
Location:Veterans Memorial Auditorium
Pamela Lu
P39: Effect of Surgical Approach on Early Return to Intended Oncologic Therapy After Resection for Pancreatic Ductal Adenocarcinoma
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Pamela Lu
Lux, Stephanie
National Institutes of Health, National Cancer Institute
40: Pre-clinical and clinical evaluation of tivozanib for Exportin 7/Ste20-like-kinase (XPO7/SLK)-expressing cholangiocarcinoma
Location:Ballroom B
Stephanie Lux
Lu, Yurong
The Ohio State University Center for Biostatistics
P5: Allostatic Load as a New Predictor of Postoperative Complications in Oncology Patients
Location:SSO HUB: Breast & Endocrine Zone
Yurong Lu
Lwin, Thinzar
City of Hope National Medical Center, Duarte, CA, United States
P48: Increased Frequency of Gene Mutations Significantly Decreases Recurrence Risk In High-Risk Stage II Melanoma Patients.
Location:SSO HUB: Melanoma & Sarcoma Zone
Thinzar Lwin
P83: Primary and Metastatic Gastric Cancers in Patient-derived Orthotopic Xenografts Brightly Labeled by Fluorescent anti-CEA Antibody
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Thinzar Lwin
Lynch, Thomas
Division of Surgical Sciences, Department of Surgery Duke University Medical Center, Durham, NC
P6: Short-term outcomes in DCIS patients managed without initial surgery
Location:SSO HUB: Breast & Endocrine Zone
Thomas Lynch
Lyu, Heather
The University of Texas MD Anderson Cancer Center
P39: Effect of Surgical Approach on Early Return to Intended Oncologic Therapy After Resection for Pancreatic Ductal Adenocarcinoma
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Heather Lyu
Back to Top
